114 related articles for article (PubMed ID: 11794965)
1. [Primary prevention of coronary thrombosis by antithrombotic agents].
Milon H; Lantelme P; Khettab F; Mestre-Fernandes C; Lasserre-Remy S
Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1243-50. PubMed ID: 11794965
[TBL] [Abstract][Full Text] [Related]
2. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
3. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
Reikvam A; Madsen S; Landmark K
Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
[TBL] [Abstract][Full Text] [Related]
4. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
5. An update on aspirin in the primary prevention of cardiovascular disease.
Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
[TBL] [Abstract][Full Text] [Related]
6. [Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].
Castaigne A; Haziza F; Lopes-Darmon ME
Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():59-63. PubMed ID: 9833081
[TBL] [Abstract][Full Text] [Related]
7. [Fibrinolysis in myocardial infarction with EKG elevation. Optimization of myocardial reperfusion by treatment with antithrombotic agents].
Jaïs C; Coste P; Labèque JN; Perron JM; Lafitte S; Zabsonré P; Roudaut R
Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1259-66. PubMed ID: 11794967
[TBL] [Abstract][Full Text] [Related]
8. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin for primary prevention of cardiovascular disease.
Bredie SJ; Wollersheim H; Verheugt FW; Thien T
Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
[TBL] [Abstract][Full Text] [Related]
10. Aspirin for primary prevention. Doctors and patients should understand potential benefits and risks of aspirin treatment.
Alkhenizan A
BMJ; 2000 Dec; 321(7274):1472-3. PubMed ID: 11187951
[No Abstract] [Full Text] [Related]
11. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
12. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
13. Primary angioplasty in acute myocardial infarction: Hypothetical estimate of superiority over aspirin or untreated controls.
Massel D
Am J Med; 2005 Feb; 118(2):113-22. PubMed ID: 15694893
[TBL] [Abstract][Full Text] [Related]
14. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.
Zuern CS; Lindemann S; Gawaz M
Semin Thromb Hemost; 2009 Apr; 35(3):295-306. PubMed ID: 19452405
[TBL] [Abstract][Full Text] [Related]
15. [Long-term antithrombotic treatment in coronary disease].
Hodara M; Samama M
J Mal Vasc; 1983; 8(1):28-32. PubMed ID: 6405004
[TBL] [Abstract][Full Text] [Related]
16. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
Zimmermann N; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
Bartolucci AA; Howard G
Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic agents in the prevention of ischemic stroke.
Bousser MG
Cerebrovasc Dis; 2009; 27 Suppl 3():12-9. PubMed ID: 19439936
[TBL] [Abstract][Full Text] [Related]
19. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
[TBL] [Abstract][Full Text] [Related]
20. Throw away the aspirin and take nonsteroidal anti-inflammatory drugs for the primary prevention of myocardial infarction.
Eliasziw M; Hill MD
Circulation; 2004 Feb; 109(7):e65-6; author reply e65-6. PubMed ID: 14981016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
